Publications
64
Citations
664
Est. group size
—
Recurring co-author estimate
Active years
38
Publishing since 1988
Andrea R. Masters conducts research in pharmacology, focusing on how drugs are processed by the body (pharmacokinetics) and how genetic differences and drug interactions affect drug metabolism. This work includes developing analytical methods to measure drugs and their breakdown products, as well as studying drug formulations such as liposomal delivery systems for cancer therapeutics. Studies span healthy volunteers, animal models, and laboratory techniques.
Publication activity has generally grown over the past decade, with a notable surge in the most recent year based on the reported counts.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Influence of CYP2B6 Pharmacogenetics on Stereoselective Inhibition and Induction of Bupropion Metabolism by Efavirenz in Healthy Volunteers
Journal of Pharmacology and Experimental Therapeutics · 2022
- Bioactivation of Sudaxine, an Agent That Increases Minute Ventilation Without Reversing Analgesia in Narcotic-Treated Animals
2022
- Pimozide Alleviates Hyperglycemia in Diet-Induced Obesity by Inhibiting Skeletal Muscle Ketone Oxidation
Cell Metabolism · 2020
- Development of Liposomal Gemcitabine with High Drug Loading Capacity
Molecular Pharmaceutics · 2019
- Development of Liposomal Gemcitabine with High Drug Loading Capacity
PMC · 2019
- Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy Volunteers
Journal of Pharmacology and Experimental Therapeutics · 2016
- Stereoselective method to quantify bupropion and its three major metabolites, hydroxybupropion, erythro -dihydrobupropion, and threo -dihydrobupropion using HPLC–MS/MS
Journal of Chromatography B · 2016
- Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy Volunteers
PMC · 2016
- Stereoselective method to quantify bupropion and its three major metabolites, hydroxybupropion, erythro-dihydrobupropion, and threo-dihydrobupropion using HPLC-MS/MS
PMC · 2016
- Alzheimer s & Dementia×5
- PMC×3
- Alzheimer s & Dementia Translational Research & Clinical Interventions×2
- Journal of Pharmacology and Experimental Therapeutics×2
- CPT Pharmacometrics & Systems Pharmacology×2
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile